A LIPOSOMAL CO-DELIVERY SYSTEM FOR DOXORUBICIN AND AN ANTI-PD-L1 NANOBODY SYNERGIZES CHEMO-IMMUNOTHERAPY IN A MURINE COLON CARCINOMA MODEL. Journal of Medical & Health Sciences Review, [S. l.], v. 2, n. 4, 2025. DOI: 10.65035/3qvcqd73. Disponível em: https://jmhsr.info/index.php/jmhsr/article/view/873. Acesso em: 23 mar. 2026.